• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review.

作者信息

Seggelke Stacey A, Ingram Claire C, Crawley Svitlana, Low Wang Cecilia C

机构信息

University of Colorado School of Medicine, Aurora, CO.

出版信息

Clin Diabetes. 2021 Apr;39(2):228-232. doi: 10.2337/cd20-0036.

DOI:10.2337/cd20-0036
PMID:33986579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8061538/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a2/8061538/4154da9b2235/diaclincd200036f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a2/8061538/4154da9b2235/diaclincd200036f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a2/8061538/4154da9b2235/diaclincd200036f1.jpg

相似文献

1
Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review.一名住院COVID-19患者的胰岛素抵抗：病例回顾
Clin Diabetes. 2021 Apr;39(2):228-232. doi: 10.2337/cd20-0036.
2
Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.新冠肺炎合并糖尿病患者极高剂量胰岛素需求：一例报告。
BMC Endocr Disord. 2020 Oct 16;20(1):155. doi: 10.1186/s12902-020-00632-2.
3
Extreme insulin resistance in a patient with diabetes ketoacidosis and acute myocardial infarction.一名患有糖尿病酮症酸中毒和急性心肌梗死患者的极端胰岛素抵抗
Case Rep Endocrinol. 2013;2013:520904. doi: 10.1155/2013/520904. Epub 2013 Jan 27.
4
Approach to the hospitalized patient with severe insulin resistance.严重胰岛素抵抗住院患者的处理方法。
J Clin Endocrinol Metab. 2011 Sep;96(9):2652-62. doi: 10.1210/jc.2011-0255.
5
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.住院COVID-19患者糖尿病管理的药物治疗考量
Expert Opin Pharmacother. 2021 Feb;22(2):229-240. doi: 10.1080/14656566.2020.1837114. Epub 2020 Oct 22.
6
SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.SARS-CoV-2 感染通过 IRF1 损害肺、肝、脂肪组织和胰腺细胞中的胰岛素/IGF 信号通路。
Metabolism. 2022 Aug;133:155236. doi: 10.1016/j.metabol.2022.155236. Epub 2022 Jun 8.
7
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.COVID-19 肺炎患者继发肺部感染的研究进展。
Infection. 2021 Aug;49(4):591-605. doi: 10.1007/s15010-021-01602-z. Epub 2021 Mar 11.
8
Insulin resistance in COVID-19 and diabetes.新型冠状病毒肺炎与糖尿病中的胰岛素抵抗。
Prim Care Diabetes. 2021 Aug;15(4):629-634. doi: 10.1016/j.pcd.2021.04.004. Epub 2021 Apr 8.
9
Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic data.新型冠状病毒肺炎患者糖尿病酮症酸中毒的发生率、特征、危险因素和结局：与流感和大流行前数据的比较。
Diabetes Obes Metab. 2023 Sep;25(9):2482-2494. doi: 10.1111/dom.15120. Epub 2023 May 30.
10
MILD CASE OF INSULIN RESISTANCE IN A PATIENT WITH TYPE 2 DIABETES MELLITUS (CASE REPORT).
Georgian Med News. 2018 Apr(277):11-14.

引用本文的文献

1
The prognostic significance of insulin resistance in COVID-19: a review.胰岛素抵抗在2019冠状病毒病中的预后意义：综述
J Diabetes Metab Disord. 2024 Jan 20;23(1):305-322. doi: 10.1007/s40200-024-01385-8. eCollection 2024 Jun.
2
Recent Patterns and Assessment of Long-term Complications followi ngSARS-CoV-2 Infection and Vaccination in the Context of Diabet esPrevalence among Blood Donors.在献血者糖尿病患病率的背景下，SARS-CoV-2 感染和疫苗接种后长期并发症的最新模式和评估。
Curr Diabetes Rev. 2024;20(9):e110124225520. doi: 10.2174/0115733998274390231110050809.
3
Insulin Requirements During Severe COVID-19 Were Relatively Low in Japanese Patients With Type 2 Diabetes: Two Case Reports.

本文引用的文献

1
A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic.在 COVID-19 大流行期间的住院糖尿病患者管理的务实方法。
J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa342.
2
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?COVID-19 影响下的高血糖患者结局：我们能否在血糖控制方面做得更好？
Diabetes Care. 2020 Jul;43(7):1408-1415. doi: 10.2337/dc20-0723. Epub 2020 May 19.
3
COVID-19 and the role of chronic inflammation in patients with obesity.
2型糖尿病日本患者在重症新型冠状病毒肺炎期间的胰岛素需求量相对较低：两例病例报告
Cureus. 2023 Oct 25;15(10):e47654. doi: 10.7759/cureus.47654. eCollection 2023 Oct.
4
Association of triglyceride-glucose index with prognosis of COVID-19: A population-based study.基于人群的研究：甘油三酯-葡萄糖指数与 COVID-19 预后的关系。
J Infect Public Health. 2022 Aug;15(8):837-844. doi: 10.1016/j.jiph.2022.06.014. Epub 2022 Jun 24.
5
Dysbiosis of Oral and Gut Microbiomes in SARS-CoV-2 Infected Patients in Bangladesh: Elucidating the Role of Opportunistic Gut Microbes.孟加拉国新冠病毒感染患者口腔和肠道微生物群失调：阐明机会性肠道微生物的作用
Front Med (Lausanne). 2022 Feb 14;9:821777. doi: 10.3389/fmed.2022.821777. eCollection 2022.
6
COVID-19 associated nervous system manifestations.COVID-19 相关的神经系统表现。
Sleep Med. 2022 Mar;91:231-236. doi: 10.1016/j.sleep.2021.07.005. Epub 2021 Jul 9.
新型冠状病毒肺炎与肥胖患者慢性炎症的关系。
Int J Obes (Lond). 2020 Aug;44(8):1790-1792. doi: 10.1038/s41366-020-0597-4. Epub 2020 May 14.
4
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
5
Hypertension and COVID-19.高血压与2019冠状病毒病
Am J Hypertens. 2020 Apr 29;33(5):373-374. doi: 10.1093/ajh/hpaa057.
6
Diabetes is a risk factor for the progression and prognosis of COVID-19.糖尿病是新冠病毒疾病（COVID-19）进展和预后的一个风险因素。
Diabetes Metab Res Rev. 2020 Oct;36(7):e3319. doi: 10.1002/dmrr.3319. Epub 2020 Apr 7.
7
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.新冠病毒肺炎住院患者基础疾病的患病率：一项系统评价与Meta分析
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.
8
COVID-19 pandemic, coronaviruses, and diabetes mellitus.COVID-19 大流行、冠状病毒和糖尿病。
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741. doi: 10.1152/ajpendo.00124.2020. Epub 2020 Mar 31.
9
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
10
15. Diabetes Care in the Hospital: .15. 医院中的糖尿病护理：。
Diabetes Care. 2020 Jan;43(Suppl 1):S193-S202. doi: 10.2337/dc20-S015.